US Patent

US8945516 — Surfactant-free water-free foamable compositions, breakable foams and gels and their uses

Formulation · Assigned to Foamix Pharmaceuticals Ltd · Expires 2030-10-01 · 4y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a surfactant-free, water-free foamable composition for delivering a tetracycline antibiotic, such as minocycline hydrochloride.

USPTO Abstract

A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant. A substantially surface active agent free composition, further comprising, a tetracycline antibiotic, or a vitamin D derivative, or one or more other active agents. A method of treatment using a substantially surface active agent free composition.

Drugs covered by this patent

Patent Metadata

Patent number
US8945516
Jurisdiction
US
Classification
Formulation
Expires
2030-10-01
Drug substance claim
No
Drug product claim
Yes
Assignee
Foamix Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.